Healthcare

Healthcare, the world's largest industry, is transforming faster than ever. The focus on outcomes based medicine and optimal health management of populations will result in major seismic shifts. Modernization and reform measures are being employed globally by public and private sector organizations to meet the growing need for healthcare. New technologies are being created, offering enormous promise to improve care delivery.

Our Transformational Health practice serves all key industry stakeholders through partnership models that provide access to high-quality content and our global team of industry experts. The practice includes Visionary Health, Life Sciences, Advanced Medical Technologies and Connected Health, focusing on evolving healthcare technologies and covering the entire industry spectrum

Showing 41-50 of 3848

11 Dec 2020  |  North America

Impact of COVID-19 on Elective Procedures in the US, 2020–2023

Growth Strategies to Navigate the Uncertainty Surrounding Elective Procedure Deferrals and their Impact on the Medical Device Market

The study offers an overview of the impact of COVID-19 on select medical devices. The deferral of elective procedures due to COVID-19-related measures has affected the cardiovascular medical device market. While some cardiovascular procedures are considered urgent, others have been rescheduled and deferred. Nearly 83.5% of all orthopedic procedures...

USD 4,950.00
11 Dec 2020  |  North America

Demand for High-Volume Testing Driving the Growth of the US Clinical Chemistry and Immunoassay In Vitro Diagnostics Market, 2020

Serology Assays for COVID-19 Diagnosis Present an Immediate Growth Opportunity

The Transformational Health team at Frost & Sullivan provides critical insights into the US clinical chemistry and immunoassay industry, highlighting the recent activities, key growth opportunities, and trends that are shaping the industry. The already dynamic in vitro diagnostics landscape in the United States was affected even more by the recen...

USD 2,450.00
11 Dec 2020  |  North America

COVID-19 Pandemic Catalyzes the Transformation of the In-vitro Diagnostics Industry

Future Growth Potential is Enriched by Alternate Testing Sites in the Point-of-Care Testing Segment

This research service provides critical insights into the impact of COVID-19 on the global in-vitro diagnostics (IVD) industry, highlighting the growth opportunities, market revenue, and technology trends that influence its growth. Its three major segments identify the strategic imperatives of the IVD industry, the impact of COVID-19 on the IVD gro...

USD 2,450.00
09 Dec 2020  |  Global

Frost Radar™: Microbiome Therapeutics, 2020

A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines

Microbiome present in the human body has a major role to play in the overall functioning of the human body. Human microbiota consists of a diverse population of bacterial, viral and eukaryotic communities and is present on skin, nasopharynx, oral cavity, respiratory tract, gastrointestinal tract and female reproductive tract. The naturally occurri...

USD 4,950.00
09 Dec 2020  |  Global

Vision 2025—Rising Healthcare Expenditures and Disproportionate Improvement in Patient Outcomes Spur Disruptive Changes in the Global Healthcare Industry

Technology-driven Transformation Offers Future Growth Potential for Stakeholders

The global healthcare industry is in the midst of a major transformation, a process that was accelerated by the COVID-19 pandemic. Several mega trends and disruptive technologies have converged to drive this transformation across the healthcare ecosystem. In this study, Frost & Sullivan builds upon previous analysis on the future of healthcare for ...

USD 1,500.00
08 Dec 2020  |  Global

Competitive Intensity Driving Healthcare Focus in the Global Consumer Wearables Market

Strategic Partnering to Drive New Healthcare Growth Opportunities for Consumer Wearables

Wearable devices have often been dismissed by healthcare professionals as a consumer tool with 'fancy' features. With several consumer wearable devices now having regulatory clearances for detecting conditions like atrial fibrillation and other cardiac conditions, their role in the healthcare landscape is becoming prominent. COVID-19 induced lockdo...

USD 2,450.00
04 Dec 2020  |  Global

Frost Radar™: Digital Biomarkers Through Connected Devices, 2020

A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines

High prevalence of complex diseases, high investments and low success rate associated with drug development, are making the health industry appeal for innovative technologies that can enhance understanding of complex diseases, contribute to the development of personalized treatments, accelerate clinical trial activities, and lower the R&D expenditu...

USD 4,950.00
02 Dec 2020  |  South Asia, Middle East & North Africa

Rise of Virtual Visits Transforming the Telehealth Market in India

Telehealth Set to Emerge as the Next Multi-Million Dollar Growth Opportunity for the Healthcare Market in India

With this research service, Frost & Sullivans Transformational Health team provides critical insights into the Indian Telehealth market, highlighting the growth opportunities, market revenue segmentation, and technology trends influencing its growth. The Telehealth market covered in this study includes three major segments—virtual visits, mHealth...

USD 4,950.00
30 Nov 2020  |  Europe

Investment in Genomics, Advanced Therapies, and Precision Health Offers New Opportunities for the UK MedTech Market

Innovation Culture in the Life Sciences Sector Enables Growth Despite the Short-term Impact of COVID-19 and Brexit

The United Kingdom (UK) medical technology (MedTech) market is experiencing a transformational phase. Although it achieved steady growth up to 2019 and was infused with investments as part of the UK Life Sciences Sector Deal, market and regulatory challenges persist. In this research study, Frost & Sullivan analyzes the UK MedTech market landscape ...

USD 4,950.00
30 Nov 2020  |  Global

Analysing Sepsis Management Part II: Treatments

Recent developments in Sepsis Treatment focused towards antibiotics, inhibitors, antibodies, peptides, recombinant proteins, antibacterial, antifungal, antivirals, vaccines, and probiotics

Sepsis is a life-threatening condition caused by overactivation of host immune system upon infections which may lead to organ failure and potentially death. World Health Organization designates sepsis as a global public health priority. Several studies conducted to understand the molecular basis of sepsis, septic shock, and organ failure. Despite e...

USD 4,950.00

Showing 41-50 of 3848